Long-term follow-up on national cancer institute phase I/II study of glioblastoma multiforme treated with iododeoxyuridine and hyperfractionated irradiation

Journal of Clinical Oncology

Volumn 10, Issue 2, 1992, Pages 264-268

  Goffman, Thomas E ^a   Dachowski, Laura J ^b   Bobo, Hunt ^b   Oldfield, Edward H ^b   Steinberg, Seth M ^b   Cook, John ^b   Mitchell, James B ^b   Katz, David ^b   Smith, Rosalie ^b   Glatstein, Eli ^b  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

IDOXURIDINE;

ADULT; ARTICLE; CLINICAL ARTICLE; DERMATITIS; GLIOBLASTOMA; HUMAN; LUNG EMBOLISM; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIOSENSITIZATION; THROMBOSIS;

ADULT; AGED; BRAIN NEOPLASMS; DRUG EVALUATION; FOLLOW-UP STUDIES; GLIOBLASTOMA; HUMAN; IDOXURIDINE; MIDDLE AGE; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY DOSAGE; SURVIVAL ANALYSIS;

EID: 0026530627     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1992.10.2.264     Document Type: Article

References (30)

1. Kinsella T, Glatstein E: Clinical experience with intravenous radiosensitizers in unresectable sarcomas. Cancer 59:908-915, 1987
2. Goffman T, Tochner Z, Glatstein E: Large and massive adult sarcomas treated with hyperfractionation and iododeoxyuridine. Cancer 67:572-576, 1991
3. Kinsella TJ, Collins J, Rowland J, et al: Pharmacology and phase I/II study of continuous intravenous infusions of iododeoxyuridine and hyperfractionated radiotherapy in patients with glioblastoma multiforme. J Clin Oncol 6:871-879, 1988
4. Jackson D, Kinsella T, Rowland J, et al: Halogenated pyrimidines as radiosensitizers in the treatment of glioblastoma multiforme. Am J Clin Oncol 10:437-443, 1987
5. Szybalski W: X-ray sensitization by halopyrimidines. Cancer Chemother Rep 58:539-557, 1974
6. Phillips TL, Bodell WJ, Uhl V, et al: Correlation of exposure time, concentration and incorporation of IdUrd in V-79 cells with radiation response. Int J Radiat Oncol Biol Phys 16:1251-1255, 1989
7. Kinsella TJ, Dobson PP, Mitchell JB, et al: Enhancement of x-ray induced DNA damage by pre-treatment with halogenated pyrimidine analogs. Int J Radiat Oncol Biol Phys 13:733-739, 1987
8. Zimbrick JD, Ward JF, Myers LS Jr: Studies on the chemical basis of cellular radiosensitization by 5-bromouracil substitution in DNA. I. Pulse and steady-state radiolysis of 5-bromouracil and thymidine. Int J Radiat Biol 16:505-523, 1969
9. Zimbrick JD, Ward JF, Myers LS Jr. Studies on the chemical basis of cellular radiosensitization by 5-bromouracil substitution in DNA II. Pulse and steady state substituted and unsubstituted DNA. Int J Radiat Biol 16:525-534, 1969
10. Sano S, Hosino T, Hagai MM: Radiosensitization of brain tumor cells with a thymidine analog (bromouridine). J Neurosurg 28:530-538, 1968
11. Greenberg HS, Chandler WF, Ensminger WD, et al: Radiosensitization with carotid arterial infusion bromodeoxyuridine and external beam radiation for gliomas, in Eisminger WD, Selam JL (eds): Update in Drug Delivery Systems. Mount Kisco, NY, Futura Publishing Co, 1989, pp 233-246
12. Russo A, Gianni L, Kinsella TJ, et al: A pharmacologic evaluation of intravenous infusion of bromodeoxyuridine (BUdR) to patients with brain tumors. Cancer Res 44:1702-1705, 1984
13. Mitchell JB, Morstyn G, Russo A, et al: Differing sensitivity to fluorescent light in Chinese hamster cells containing equally incorporated quantities of BUdR versus IUdR. Int J Radiat Oncol Biol Phys 10:1447-1451, 1984
14. Burger PC, Vogel FS: Surgical pathology of the nervous system (2nd ed). New York, NY, Wiley, 1982, pp 240-266
15. Kaplan EL, Meier P: Non-parametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
16. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163-170, 1966
17. Cox D: Regression models and lifetables. J R Stat Soc [B] 34:187-202, 1972
18. Daniel WW: Biostatistics: A Foundation for Analysis in the Health Sciences (2nd ed). New York, NY, John Wiley and Sons, 1978, pp 159-163
19. Larson DA, Gutin PA, Leibel SA, et al: Stereotaxic irradiation of brain tumors. Cancer 65:792-799, 1990
20. Sundaresan N, Galicick JH, Deck MDF, et al: Radiation necrosis after treatment of solitary intracranial metastasis. Neurosurgery 8:229-233, 1981
21. Walker MD, Green SB, Byar DP, et al: Randomized comparisons of radiotherapy and nitrosureas for the treatment of malignant glioma after surgery. N Engl J Med 303:1323-1329, 1980
22. Walker MD, Alexander E, Hunt WE, et al: Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas: A cooperative clinical trial. J Neurosurg 49:333-343, 1978
23. Anderson AP: Post-operative irradiation of glioblastoma Results in a randomized series. Acad Radiat Oncol 17:475-484, 1978
24. Deutsch M, Green SB, Strike TA, et al: Results of a randomized trial comparing BCNU and radiotherapy, streptozotocin and radiotherapy, BCNU and hyperfractionation and BCNU following misonidazole and radiotherapy in the post operative treatment of malignant glioma. Int J Radiat Biol Phys 16:389-391, 1989
25. Levin VA, Wara WM, Gutin CP, et al: Initial analysis of NCOG 6G82-1: Bromodeoxyuridine (BUdR) during irradiation followed by CCNU, procarbazine and vincristine (PCV) chemotherapy. Int J Radiat Oncol Biol Phys (in press)
26. Fertil B, Malaise EP: Intrinsic radiosensitivity of human cell lines correlated with radioresponsiveness of human tumors: Analysis of 101 published survival curves. Int J Radiat Oncol Biol Phys 11:1699-1707, 1985
27. Gerweck LE, Kornblith PL, Burlett P, et al: Radiation sensitivity of cultured human glioblastoma cells. Radiology 125:231 234, 1977
28. Schultz CJ, Geard CR: Radioresponse of human astrocytic tumors across grade as a function of acute and chronic irradiation. Int J Radiat Biol Oncol Phys 19:1397-1404, 1990
29. Deutsch M, Revers AB, Redgate S, et al: Intracerebral ventricular infusion of 5-iodo 2 deoxyuridine (IUdR) as a radiosensitizer in the treatment of rat gliomas. Int J Radiat Biol Oncol Phys 19:85-87, 1990
30. Kassis AI, Van der Abbeele AD, Wen PY, et al: Specific uptake of the auger emitting thymidine analogue 5(I-125/RS iodo 2′deoxyuridine) in rat brain tumors: Diagnostic and therapeutic implications in humans. Cancer Res 50:5199-5203, 1990